eyenovia-logo 3

Investor Relations

Investor Relations

Corporate Profile

Our Vision is to Improve Yours. Eyenovia is a public eye care company with topical ophthalmic therapies that are easier to use and easier to live with. The Optejet® is the only FDA-approved ophthalmic spray alternative to eye drops.

Presentation & Investor Materials

Price

Change
 
Volume

Minimum 15 minutes delayed. Source: LSEG

Recent News Releases
01/15/25
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders
Read More
01/06/25
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives
Read More
12/06/24
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering
Read More
Upcoming Events
There are currently no events scheduled.
Copyright © Eyenovia, Inc. All rights reserved.